You are here

Article info

Article menu
Download PDFPDF
Commentary
Oral antiviral therapy for hepatitis B: the case of besifovir, a new kid on the block with a long way to go

Authors

  1. Correspondence to Dr Pietro Lampertico, 1st Division of Gastroenterology, “A.M. e A. Migliavacca” Center for the Study of Liver Disease, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Università degli Studi di Milano, Via F Sforza 35-20122 Milan, Italy; pietro.lampertico{at}unimi.it
View Full Text

Citation

Lampertico P
Oral antiviral therapy for hepatitis B: the case of besifovir, a new kid on the block with a long way to go
Gut 2014;63:869-870.

Publication history

  • Received October 4, 2013
  • Revised October 7, 2013
  • Accepted October 8, 2013
  • First published October 25, 2013.
Online issue publication 
April 18, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions